| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $455.7M | +82.8% |
| Cost of Revenue | $318.8M | +70.0% |
| Gross Profit | $136.9M | +121.5% |
| R&D Expense | $85.5M | +55.6% |
| SG&A Expense | $75.7M | +27.1% |
| Operating Income | -$54.6M | +23.0% |
| Pre-tax Income | -$46.7M | +75.0% |
| Income Tax | -$8.5M | — |
| Net Income | -$38.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $206.1M | +205.7% |
| Accounts Receivable | $244.4M | +109.2% |
| Inventory | $183.1M | +107.8% |
| Current Assets | $675.7M | +124.3% |
| Total Assets | $1.17B | +113.6% |
| Current Liabilities | $257.3M | +51.3% |
| Long-term Debt | $34.0M | +27.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$174.4M | -150.9% |
| Capital Expenditures | $179.1M | +312.7% |
| Investing Cash Flow | -$210.6M | -315.4% |
| Financing Cash Flow | $527.9M | +271.3% |
| Free Cash Flow | -$353.6M | -213.1% |
| +79.5% |
| EPS (Basic) | -$0.64 | +85.8% |
| EPS (Diluted) | -$0.64 | +85.8% |
| Total Liabilities |
| $434.5M |
| +36.7% |
| Stockholders' Equity | $733.9M | +220.3% |